A thrombolytic agent which works by converting plasminogen to plasmin in order to degrade fibrin. Alteplase is marketed by Genentech, Inc. as Activase(R) for use in acute myocardial infarction, acute ischemic stroke and acute massive pulmonary embolism and Cathflo(R)Activase(R) for the restoration of function to central venous access devices.